JPWO2023145831A1 - - Google Patents
Info
- Publication number
- JPWO2023145831A1 JPWO2023145831A1 JP2023576985A JP2023576985A JPWO2023145831A1 JP WO2023145831 A1 JPWO2023145831 A1 JP WO2023145831A1 JP 2023576985 A JP2023576985 A JP 2023576985A JP 2023576985 A JP2023576985 A JP 2023576985A JP WO2023145831 A1 JPWO2023145831 A1 JP WO2023145831A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022012146 | 2022-01-28 | ||
| PCT/JP2023/002470 WO2023145831A1 (ja) | 2022-01-28 | 2023-01-26 | 網膜色素変性症を治療するための医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023145831A1 true JPWO2023145831A1 (https=) | 2023-08-03 |
| JPWO2023145831A5 JPWO2023145831A5 (https=) | 2025-07-10 |
Family
ID=87471563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023576985A Pending JPWO2023145831A1 (https=) | 2022-01-28 | 2023-01-26 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250144041A1 (https=) |
| EP (1) | EP4470531A4 (https=) |
| JP (1) | JPWO2023145831A1 (https=) |
| CN (1) | CN119031907A (https=) |
| WO (1) | WO2023145831A1 (https=) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008026702A1 (fr) * | 2006-08-30 | 2008-03-06 | Kyushu University, National University Corporation | Composition pharmaceutique contenant une nanoparticule de statine encapsulée |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004149480A (ja) * | 2002-10-31 | 2004-05-27 | Saisentan Igaku Kenkyusho:Kk | 経口又は経皮投与用の眼科疾患治療剤 |
| WO2004103960A2 (en) * | 2003-05-16 | 2004-12-02 | Ambit Biosciences Corporation | Compounds and uses thereof |
| WO2008044339A1 (en) * | 2006-10-13 | 2008-04-17 | Aqumen Biopharmaceuticals K.K. | Therapeutic/preventive agent for intraocular disease containing statin compound |
| CN101959542B (zh) * | 2007-12-25 | 2014-11-12 | 国立大学法人山口大学 | 药物传递系统 |
| JP2023517582A (ja) * | 2020-03-11 | 2023-04-26 | ウニヴェルジテート レーゲンスブルク | 眼疾患の処置における使用のためのナノ粒子 |
| JP6978016B1 (ja) | 2020-07-01 | 2021-12-08 | 株式会社システムフォワード | 来場者管理システム及び来場者管理方法 |
-
2023
- 2023-01-26 JP JP2023576985A patent/JPWO2023145831A1/ja active Pending
- 2023-01-26 WO PCT/JP2023/002470 patent/WO2023145831A1/ja not_active Ceased
- 2023-01-26 EP EP23747041.4A patent/EP4470531A4/en active Pending
- 2023-01-26 US US18/832,713 patent/US20250144041A1/en active Pending
- 2023-01-26 CN CN202380030920.5A patent/CN119031907A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008026702A1 (fr) * | 2006-08-30 | 2008-03-06 | Kyushu University, National University Corporation | Composition pharmaceutique contenant une nanoparticule de statine encapsulée |
Non-Patent Citations (3)
| Title |
|---|
| KENZO ICHIMURA ET AL.: "Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intrav", INTERNATIONAL HEART JOURNAL, vol. 59, JPN6026005382, 2018, pages 1432 - 1444, ISSN: 0005797172 * |
| SHUNSUKE KATSUKI ET AL.: "Nanoparticle-Mediated Delivery of Pitavastatin Inhibits Atherosclerotic Plaque Destabilization/Ruptu", CIRCULATION, vol. 129, JPN6026005383, 25 February 2014 (2014-02-25), pages 896 - 906, ISSN: 0005797173 * |
| 舩津淳: "単球/マクロファージを標的とした網膜色素変性に対する新規ナノ粒子治療薬の開発", 日本眼科学会雑誌, vol. 第124回臨時増刊号, JPN6026005381, 13 March 2020 (2020-03-13), pages 1 - 081, ISSN: 0005797171 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023145831A1 (ja) | 2023-08-03 |
| EP4470531A1 (en) | 2024-12-04 |
| CN119031907A (zh) | 2024-11-26 |
| US20250144041A1 (en) | 2025-05-08 |
| EP4470531A4 (en) | 2026-01-14 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250702 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250702 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260217 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260415 |